Here's why the Anteotech (ASX:ADO) share price is spiking 13% today

The biotech company share price is well into the green today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Anteotech Ltd (ASX: ADO) are spiking well into the green during afternoon trade and now change hands 12.5% higher at 22.5 cents apiece.

Whilst there's been no market-sensitive information from the company's end today, Anteotech did advise of an approximate $2 million research & development (R&D) tax incentive refund it received in an announcement.

Lab worker puts hands in the air and dances around

Image source: Getty Images

What did Anteotech announce?

AnteoTech advised that it has received a cash refund of $1,965,463 under the Federal Government's R&D Tax Incentive Scheme.

The rebate relates to eligible R&D activities conducted by AnteoTech in both its Life Science and Energy divisions for the 2021 financial year, per the release.

For reference, the R&D Tax Incentive is an Australian Government program developed to assist businesses to "access tax offsets for expenditure on eligible research and development activities".

This refundable tax offset amounts to 43.5% of the expenditure on eligible research and development activities undertaken during the financial year.

Anteotech says that the funds will be reinvested into the continued development of its lateral flow test product
offerings for the EuGeni platform, with the remainder assigned to the AnteoX (cross-linker additive) program that is targeting increased electrode coating cohesion of lithium-ion battery electrodes.

Today's update follows on from previous news Anteotech released last week advising that the Therapeutic Goods Administration (TGA) had contacted the company requesting it to review how its diagnostic test will cover COVID-19 variants.

This comes on the back of earlier momentum where the company claimed its rapid nasal swab test was successful in detecting COVID-19 in 1 minute with an efficacy of 97.3%.

Despite the series of updates, the market has expected more from the company and has thus punished its share price over the last 3 months.

In that time, Anteotech's shares have crumbled off a high of 27.5 cents to trade as low as 17 cents last week. However, following the update, they have reclaimed some territory and are now up 25% for the week and 13% for the month.

Anteotech share price summary

Despite the challenges in recent months, the Anteotech share price has climbed over 120% in the last 12 months, after rallying another 109% this year to date.

It has wobbled these past 6 months and has tested the 29 cents per share mark twice without success, and has been forced to bounce off a low of around 16–19 cents twice now.

One reason Anteotech is up so much over the longer time frames is that it is coming off a low base. In December 2020 it was trading at 10.5 cents, whereas it has reached a 52-week high of 43.5 cents in April and a 52-week low of 10 cents in February 2021.

The author has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »